Bloomberg: Sale of OTC specialist Omega could top $5.3B with bids from Bayer, Sanofi

August 29, 2014 | By Carly Helfand

What's an OTC drugmaker worth in the race to the top of the consumer healthcare space? Potentially more than $5.3 billion, if that drugmaker is Belgium's Omega Pharma.

The up-for-sale company has so far drawn interest from suitors including Perrigo ($PRGO) and Boehringer Ingelheim, and the big guns--Bayer and Sanofi ($SNY)--may get involved, too, Bloomberg's sources say. According to those sources, the sale--still in its early stages--could bring in more than